ChenGuang Biotech Group バランスシートの健全性
財務の健全性 基準チェック /36
ChenGuang Biotech Group has a total shareholder equity of CN¥3.1B and total debt of CN¥4.0B, which brings its debt-to-equity ratio to 129.8%. Its total assets and total liabilities are CN¥7.7B and CN¥4.6B respectively. ChenGuang Biotech Group's EBIT is CN¥311.5M making its interest coverage ratio 4.9. It has cash and short-term investments of CN¥2.6B.
主要情報
129.8%
負債資本比率
CN¥4.04b
負債
| インタレスト・カバレッジ・レシオ | 4.9x |
| 現金 | CN¥2.55b |
| エクイティ | CN¥3.11b |
| 負債合計 | CN¥4.64b |
| 総資産 | CN¥7.75b |
財務の健全性に関する最新情報
更新なし
Recent updates
A Piece Of The Puzzle Missing From ChenGuang Biotech Group Co., Ltd.'s (SZSE:300138) 43% Share Price Climb
Oct 08
ChenGuang Biotech Group (SZSE:300138) Might Be Having Difficulty Using Its Capital Effectively
Sep 30Return Trends At ChenGuang Biotech Group (SZSE:300138) Aren't Appealing
May 13Impressive Earnings May Not Tell The Whole Story For ChenGuang Biotech Group (SZSE:300138)
Apr 25ChenGuang Biotech Group Co., Ltd. (SZSE:300138) Just Reported, And Analysts Assigned A CN¥17.66 Price Target
Apr 21財務状況分析
短期負債: 300138's short term assets (CN¥5.6B) exceed its short term liabilities (CN¥3.1B).
長期負債: 300138's short term assets (CN¥5.6B) exceed its long term liabilities (CN¥1.5B).
デット・ツー・エクイティの歴史と分析
負債レベル: 300138's net debt to equity ratio (47.7%) is considered high.
負債の削減: 300138's debt to equity ratio has increased from 65.7% to 129.8% over the past 5 years.
債務返済能力: 300138's debt is not well covered by operating cash flow (0.8%).
インタレストカバレッジ: 300138's interest payments on its debt are well covered by EBIT (4.9x coverage).